Search results
S&P 500 declines, Nasdaq falls 2% in a rare event on Wall Street after 45 years - CNBC TV18
CNBC TV18· 11 hours agoThe US markets had a mixed day on Thursday as benchmark indices saw sharp cuts but the broader...
Pfizer along witth Eli Lilly and Novo Nordisk, enroute to develop their second generation weight...
CNBC TV18· 19 hours agoPfizer plans to move a reworked, once-a-day version of its weight loss pill, danuglipron, into...
Flagship raises $3.6B for biotech investing
BioPharma Dive· 2 days agoAll told, Flagship now has an aggregate capital pool of $10.9 billion and $14 billion of assets...more than 100 employees with a pipeline of 10...
Pfizer's chief scientist Mikael Dolsten to step down - ET HealthWorld | Pharma
The Economic Times· 2 days agoDuring his tenure, Comirnaty - jointly developed by Pfizer and BioNTech - became the first COVID ...
Pfizer's key scientist Mikael Dolsten, who developed Covid vaccine, to step down - Times of India
The Times of India· 3 days agoLast year, Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer,...
Pfizer research chief Dolsten to step down, with company at a crossroads
BioPharma Dive· 3 days agoThe company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and ...
Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births - ET HealthWorld |...
The Economic Times· 3 days agoLondon: Pfizer's respiratory syncytial virus (RSV) vaccine for pregnant women was not tied to a...
UK pharma group reprimands Novo Nordisk for undisclosed payments
Pharmaceutical Technology· 4 days agoGlobalData is the parent company of Pharmaceutical Technology. Pfizer’s transgression was promoting...
Mice With Functional Humanised Immune System Shows Promise
Latest India News· 6 days agoTo date, researchers have not developed a fully functional human immune system.
J&J’s patent application for kids’ TB drug rejected | India Business News - Times of India
The Times of India· 6 days agoNEW DELHI: In good news for children suffering with TB, more affordable versions of a life-saving TB drug will be soon available in the country. The Indian Patent Office on Friday rejected US ...
